Luciano Mutti, MD, professor of Cancer Research, University of Salford Manchester, discusses the current role of immunotherapy for patients with mesothelioma.
Luciano Mutti, MD
Advertisement
Articles by Luciano Mutti, MD
Luciano Mutti, MD, professor in Cancer Research, University of Salford Manchester, discusses predicting clinical response to immunotherapy agents for patients with mesothelioma.
Advertisement
Latest Updated Articles
Dr. Mutti on Predicting Response to Immunotherapy for MesotheliomaDecember 15th 2016
Dr. Mutti on Current Role of Immunotherapy for MesotheliomaFebruary 8th 2017
Advertisement
Advertisement
Trending on OncLive
1
Sacituzumab Govitecan Approved in Europe for First-Line PD-L1 Inhibitor–Ineligible TNBC
2
Sigvotatug Vedotin Fails to Improve OS in Advanced, Pretreated Nonsquamous NSCLC
3
Allogeneic BCMA CAR T-Cell Therapy CT0596 Elicits 100% ORR in R/R Myeloma and Plasma Cell Leukemia
4
NCCN Includes PCR ctDNA-MRD Testing in MIBC Treatment Algorithm
5